Sinopharm Group Co. Ltd. (1099.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 54.49B |
| Enterprise Value | 101.53B |
| P/E Ratio | 5.84 |
| PEG Ratio | 1.82 |
| Price/Sales Ratio | 0.07 |
| Price/Book Ratio | 0.48 |
| Enterprise/Revenue | 0.2 |
| Enterprise/EBITDA | 5.49 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 575.17B |
| Revenue/Share | 182.03 |
| Gross Profit | 41.67B |
| EBITDA | 19.26B |
| Net Income | 7.16B |
| Diluted EPS | 2.29 |
Balance Sheet
| Total Cash | 41.88B |
| Total Cash/Share | 13.42 |
| Total Debt | 113.77B |
| Total Debt/Equity | 1.34 |
| Current Ratio | 1.4 |
| Book Value Per Share | 43.68 |
Price History
| 52-Week Change | -19.2 |
| 52-Week High | 22.34 |
| 52-Week Low | 15.22 |
| Moving Average 50 Days | 16.71 |
| Moving Average 200 Days | 18.89 |
Statistics
| Average Volume | 5.62M |
| Shares Outstanding | 3.12B |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.68 |
| Trailing Annual Dividend Yield | 5.14 |
| Payout Ratio | 0.3 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
